Pamlab
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Pamlab sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Pamlab: 8 sponsored US clinical trials, none currently recruiting.
Pamlab sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimers Disease, with 2 trials.
Upper-quartile sponsor footprint
Pamlab sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
NCT01745198
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
NCT01370954
Néevo®/NéevoDHA® P.L.U.S. Program (Progress Through Learning, Understand & Support)
NCT01358552
Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)
NCT01369030
A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
NCT01091506
A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
NCT01062958
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
NCT01001559
Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
NCT00726713
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
How the Pamlab archive is shaped
8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Alzheimers Disease (2 trials), 5 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Pamlab: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Pamlab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Pamlab page
8 registered trials is a research-attention snapshot, not an endorsement of Pamlab or any single study.
- None of Pamlab's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Alzheimers Disease is the condition Pamlab studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimers Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pamlab pipeline card: 8 registered trials from official public datasets.Report a data error.